Acrivon Therapeutics Inc. Common Stock (ACRV)
1.50
-0.14 (-8.54%)
At close: Apr 04, 2025, 3:59 PM
1.55
3.64%
After-hours: Apr 04, 2025, 05:03 PM EDT
Acrivon Therapeutics Common Stock Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
18
Upside
1100.00
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| HC Wainwright & Co. | Buy | Reiterates | 19 19 | 1166.67% | Mar 28, 2025 | |
| Cantor Fitzgerald | Buy | Initiates | n/a | n/a | Mar 26, 2025 | |
| Citizens Capital Markets | Buy | Reiterates | 17 17 | 1033.33% | Mar 26, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.
We use cookies to ensure that we give you the best experience on our website. Read Privacy Policy.